ããã¯ãã¼ã¯ãã¾ãã ããã«ãã¤ã¼ãå 容ãè¨è¼ããã¾ã https://b.hatena.ne.jp/URLã¯spanã§å²ãã§ãã ãã Twitterã§å ±æ
2021å¹´ããã®ä¸ç 人é¡ã®æªæ¥ 人é¡ã®è¦éã¨çå® æªéã®è¼ªé æ¥æ¬ã®æªæ¥ è»äºçã«ãªã¹ åçå´åççºè¡¨ã®ãã³ããã¯ã¯ãã³ãåå ã®æ¥æ¬ã®æ»äº¡è ã¯ã¼ããã®è³æãè¦ã¦æããæ¦æä¸æããããã¦ãä¸å½è»ã®çç©å µå¨éçºã®å ¬å¼è³æã«æããã®ç¾å®æ ãã³ããã¯ã¯ãã³ãåå ã§äº¡ããªã£ã人ã¯ä¸äººããã¾ããã åçå´åçã®ã¦ã§ããµã¤ãã§ã¯ãå®æçã«ã³ããã¯ã¯ãã³ã®ãå¯åå¿çãã®å ±åãã¨ãããã®ãæ²è¼ãã¦ãã¾ãã ãã®ä¼ã®æ£å¼å称ã¯ãå½äºè ãã¡ãå¤åæ¶ãããã¦ããªãã®ã§ã¯ãªããã¨æããããªä»¥ä¸ã®ãã®ã§ããªã³ã¯ã¯ãã®ææ°ã®ç¬¬62å調æ»ä¼ã®ãã¼ã¸ã§ãã ã第62ååçç§å¦å¯©è°ä¼äºé²æ¥ç¨®ã»ã¯ã¯ãã³åç§ä¼å¯åå¿æ¤è¨é¨ä¼ã令åï¼å¹´åº¦ç¬¬11åè¬äºã»é£åè¡ç審è°ä¼è¬äºåç§ä¼å»è¬åçå®å ¨å¯¾çé¨ä¼å®å ¨å¯¾ç調æ»ä¼ï¼ååéå¬ï¼è³æã ï¼è©²å½ãã¼ã¸ï¼ ãé£åè¡ç審è°ä¼â¦ãããå§ã¾ãæåã®é£ãªãã¯ç©ºç½ãå¥èªç¹ãä¸åãªããã¾ãã§æ¼¢è©©ã®ãã
2021.07.07 è¦åããã¦ããéãããï½RNAã¯ã¯ãã³ããæ¥ç¨®ããç´å¾ã«å¿èãæ£ãè¥è ã«ãã´ãªï¼ã«ãã´ãªæªåé¡ ã¢ã¡ãªã«ã«ã¯ææ¥ã«åºå¸ããæ¡ä»¶ã¨ãã¦ãCOVID-19ï¼2019å¹´-ã³ããã¦ã¤ã«ã¹ææçï¼ã¯ã¯ãã³ãã®æ¥ç¨®ãè¦æ±ããå¦æ ¡ããããããã§âBioNTechï¼ãã¡ã¤ã¶ã¼è£½ã®ãã¯ã¯ãã³ããæããããããªãã£ã17æ³ã®çå¾ãæ¥ç¨®ãã1é±éå¾ã«å¿èç âã«ãªããææ¥å¦ç½®å®¤ã¸éã³è¾¼ã¾ãããã¨ã«ãªã£ãã¨ããã ã¤ã¹ã©ã¨ã«ã§ã¯ä»å¹´4æããâCOVID-19ã¯ã¯ãã³ããæ¥ç¨®ããå¾ã«å代ã®è¥è ãå«ã人ã³ã¨ã®éã§å¿ççãå¿èçãå¼ãèµ·ããäºä¾âãè¦ã¤ãããåé¡ã«ãªã£ããã¢ã¡ãªã«ã§ãä¼¼ãäºä¾ãè¦ã¤ãããã¢ã¡ãªã«è»ã®èª¿æ»ã§ãmRNAï¼ã¡ãã»ã³ã¸ã£ã¼RNAï¼æè¡ã使ã£ããã¡ã¤ã¶ã¼è£½ã¨ã¢ãã«ã製ã®ãCOVID-19ã¯ã¯ãã³ããå¿ççãå¼ãèµ·ããã¨ããçµæãåºã¦ããã ã¢ã¡ãªã«ã«ãããä¼æç 対çã®æ ç¹ãâ
æè¿åæé®®ã®å容æã«é¢ãããã¥ã¼ã¹ãè¦ãã®ã§ãããä¸å½ã«æã¾ãã人ã«å¯¾ãã¦æ·åãããã¨ããã¦ãã¦æ¬å½ã²ã©ãã§ããâ¦ãã§ãæ¥æ¬ã§ãæã¯ãããã£ãæ·åã¨ããæ®éã«è¡ããã¦ãã¨èãã¾ãããå®éãæ¥æ¬ã§ã¯ãã¤ãããããã£ãæ·åã¨ãä¸å½é®æããªããªã£ãã®ã§ããããï¼ æ¥æ¬ã§ã¯ãææ²»æ²æ³ä¸ã«ããã¦ã¯äººèº«ã®èªç±ãä¸å½ã«å¶éãããããªé®æãæ·åã¨ããè¡ããã¦ãããã ãã©ãæ¦å¾æ¥æ¬å½æ²æ³ãã§ãã¦ããã¯ãéå»ã®åçãã人身ã®èªç±ããã£ããã¨ä¿éããããã«ãªã£ããã ããå ¬åå¡è©¦é¨ã§ã¯åºé¡ã¯å¤ããªãé¨åã§ã¯ãããã©ãããã§ãåºé¡ããããã¨ã¯ãããããä»æ¥ã¯ã人身ã®èªç±ãã«ã¤ãã¦åå¼·ãã¦ããããã 人身ã®èªç±ã¨ã¯ï¼ æ²æ³18æ¡ã«ããã奴é·çææã»è¦å½¹ããã®èªç±ã¨ã¯ï¼ æ²æ³31æ¡ã«ãããé©æ£æç¶ãã®ä¿éã¨ã¯ï¼ åäºè£å¤æç¶ãã«é¢ããè¦å®(33æ¡ï½39æ¡) 被çè ã®æ¨©å©(33ï½35æ¡) 被å人ã®æ¨©å©(37ï½39æ¡) 人
ä¸ã®ä¸ å»çå¾äºè ã¯æ°åã³ããã¯ã¯ãã³æ¥ç¨®ã義åã¨ãã¹ããï¼å¿½é£è³¢å¿ï¼ - ã¨ãã¹ãã¼ã - Yahoo!ãã¥ã¼ã¹
ã©ããªã¨ãã§ãå·éã§ãææ çã«ãªããã¨ã¯ãã£ãã¦ãªãââå»å¸«ã«å¯¾ãã¦ããããã¤ã¡ã¼ã¸ãæ±ãã¦ãã人ã¯å°ãªããªãã ãããã ããã¡ãããå½¼ãã人ã®åã§ãããããããã¤ã¡ã¼ã¸ãã®ã¾ã¾ã§ããããããªãããµã ãã¯ã©ããªã«å·éãªå»å¸«ã§ãã£ã¦ããã¨ãã¨ãã¦å¼·åãªææ ã«å§åããã¦ãã¾ããã¨ãããã¯ãã ããããªãã°ãå»å¸«ã¯ç¾å ´ã§å®éã«ã©ããªææ ãæ±ãã¦ããã®ããããã¦ãããããææ ã¯å»çè¡çºã«ã©ã®ãããªå½±é¿ãä¸ãã¦ããã®ããæ¬æ¸ã¯ããããªåé¡ã«å ãå½ã¦ããã¨ãããã¢ã¡ãªã«ã®ç¾å½¹å»å¸«ã«ããã«ãã«ã¿ã¼ã¸ã¥ã§ããã æ¬æ¸ã¯ã¾ããå ±æãã®è©±ããå§ã¾ããããã§ããå ±æã¨ã¯ããä»äººã®è¦ç¹ã§ãã®ãè¦ã¦ãæãããã¨ã®ã§ããè½åãããããã¯ãã£ã¨éå®çã«ã¯ããæ£è ã®è¦çãèªèããç解ãããã¨ãã§ãããããè¨ãããããã«ãå»å¸«ã¯æ£è ã«å¯¾ãã¦ãåæ ãããå¿ è¦ã¯ãªããããããªãããããããããã診æã¨æ²»çãè¡ããã¨ããã®ã§ããã°ã
ç«æ²æ°ä¸»å ã®æ§ç¯ç½ªåæ³æ¹æ£ã¯ã¼ãã³ã°ãã¼ã ï¼WTï¼åº§é·ã®å¯ºç°å¦è¡é¢è°å¡ã¯8æ¥ãWTä¼åã§ã®æ¬å¤å¹³ç´è¡é¢è°å¡ã®ã50æ³ã¨14æ³ãåææ§äº¤ãã¦ãæã¾ãã®ã¯ãããããã¨ãã趣æ¨ã®çºè¨ãªã©ã«åè«ããè¦è§£ãçºè¡¨ãããWTã¯åæ³ãæ¹æ£ããæ人ãæ§è¡çºãããå ´åã«ç½ªã«åããã対象年齢ãç¾å¨ã®13æ³æªæºãã16æ³æªæºã«å¼ãä¸ããæè¨ã«ã¤ãã¦è°è«ãã¦ããã寺ç°æ°ã®è¦è§£ã¯ä»¥ä¸ã®éãã
ï¼»ãã³ãã³ãï¼æ¥ããã¤ã¿ã¼ï¼½ - è±äºç®è²¬ä»»å±ï¼ï¼¯ï¼¢ï¼²ï¼ã¯ï¼æ¥ãï¼ï¼ï¼ï¼å¹´ã¾ã§ã«æ¸©å®¤å¹æã¬ã¹ã®æåºãå®è³ªã¼ãã«ããã¨ããç®æ¨éæã«åããåãçµã¿ãå ¬çåµåã«åã¼ãå½±é¿ã«ã¤ãã¦ãæ¿åºãè¿ éã«å¯¾å¿ãããã¨ãåæã«ãæ°åã³ããã¦ã¤ã«ã¹ã®ãã³ãããã¯ï¼ä¸ççæµè¡ï¼ã»ã©æ·±å»ã§ãªãå¯è½æ§ãããã¨ã®è¦è§£ã示ããã OBRãçºè¡¨ããæ¿åºè²¡æ¿ãç´é¢ãããªã¹ã¯ã«é¢ããå ±åæ¸ã«ããã¨ãæ¿åºãæ°åå¤å対çã«æ©æã«åãçµãã å ´åãï¼ï¼ï¼ï¼ï¼ï¼ï¼å¹´ã®å ¬çé¨éç´åµåã¯å½å ç·çç£ï¼ï¼§ï¼¤ï¼°ï¼æ¯ï¼ï¼ï¼ ãç¾å¨ã®ï¼§ï¼¤ï¼°ã§æç®ãã¦ï¼ï¼ï¼ï¼åãã³ãï¼ï¼ï¼ï¼ï¼åãã«ï¼å¢å ããããããã¯ããã³ãããã¯ã«èµ·å ããå¢å ãè¥å¹²ä¸åããã¨ãã¦ããã
ä¸ã®ä¸ 竹ä¸å¹³èµ â天æµâ ãåããæ¿åãã¸ã®åè½ãå°æ³æ代ã¯ã¾ã ãã·ã ã£ããï¼SmartFLASHï¼ - Yahoo!ãã¥ã¼ã¹
ãèªå£²æ°èããèªæ°å ã¨é½æ°ãã¡ã¼ã¹ãã®ä¼ããå å·®ã§ç¬¬ï¼å ã¨ç¬¬ï¼å ã®åº§ã交代ããçµæã¨ãªã£ãé½è°é¸ãèªæ°ã¯å ¬æå ã¨åããã¦ãéåæ°ã«å±ãããå¤æ°æ´¾ãå½¢ä½ãã«ã¯ããã®ï¼å ãä¸å¿ã¨ããåå ãã©ãååé¢ä¿ãçµã¶ããç¦ç¹ã¨ãªãããé½æ°ãã¡å½é¸
PCRæ¤æ»ã«é¢ããæè¡ç観ç¹ãããå ¬çæ©é¢ã®ææè æ°çºè¡¨ãé°æ§è¨¼ææ¸ã«é¢ãã¦ã¯ããã£ã¨ç念ãæã£ã¦ããããããå¦è¡ã®ä¸çã§ã¯æ¥µãã¦æ£å½ãªå¯¾å¿ããªããã¦ãããç±³å½ææçå¦ä¼ï¼Infectious Diseass Society of America, IDSAï¼ã®ã¬ã¤ãã©ã¤ã³ã¯å¦¥å½ãªãã®ã§ãç§å¦çã«æ£ããæéãæ示ãã¦ããããã®æéã¯æ°åã³ããã¦ã¤ã«ã¹æµè¡åæã®PCRæ¤æ»ã®Ctå¤åæããã¨ã«ãã¦ããï¼ï¼ï¼ã ç±³å½ææçå¦ä¼ IDSA ã®ã¬ã¤ãã©ã¤ã³ IDSAã¯ãï¼ï¼COVID-19ã®çç¶ã®ãã人ãï¼ï¼ç¡çç¶ã ãCOVID-19æ£è ã¨ã®æ¥è§¦æ´ããããã¯æ¥è§¦ã®çãã®ããå ´åãï¼ï¼ç¡çç¶ã ãã診æçµæãéé¢çã®å¤æã«å½±é¿ããå ´åãå¤ç§æè¡ã®å®æ½ã«å½±é¿ããå ´åãå ç«æå¶å¤ã®æä¸ã«å½±é¿ããå ´åããã®ä¸ç¨®é¡ã®ã±ã¼ã¹ã«ã¤ãã¦PCRæ¤æ»ãæ¨å¥¨ãããã¨ãã¦ããã ããªãã¡ã ã»è¨åºçæè¦ã§å¯è½æ§ãä½ãã¦ãçç¶
æ°åã³ããã¦ã¤ã«ã¹ï¼SARS-CoV-2ï¼ã®èµ·æºã¯ä»å¾ã®ãã³ãããã¯å¯¾çãç«ã¦ãä¸ã§æ±ºå®çãªè¦å ã ãèªç¶çºçã¨ç 究ææµåºã§ã¯å¯¾çãç°ãªã£ã¦ãããã¾ããç 究æããæµåºããã¦ã¤ã«ã¹ãéçæ ªã§ã¯ãªã人工çã«éºä¼åæ¹å¤ããããã®ã§ããã°å»å¦çãããã¯å ¬è¡è¡çå¦çåé¡ã§ã¯ãªã社ä¼åé¡ã§ããããã³ãããã¯åæãããã£ã¨èªç¶çºç説ã主æµã§ãã£ãããï¼ææ«ã«æ¬§ç±³ã®ä¸»æµã¡ãã£ã¢ã®è«èª¿ãããããç¾å¨ã¯éºä¼åæ¹å¤ãããã¦ã¤ã«ã¹ãç 究æããæµåºãããã¨ã¯ãã»ã¼ç¢ºå®ãã¦ããã ããã¾ã§ã®çµç·¯ ãã³ãããã¯åæããæ¦æ¼¢ç 究æããã¦ã¤ã«ã¹ãæµåºããã¨ããåã¯ãã£ããã主æµã¡ãã£ã¢ã¯é°è¬è«ã¨ãã¦æ±ã£ã¦ãããå¦è¡é¢ã§æ±ºå®çãªåºæ¥äºã¯ãï¼ï¼ï¼ï¼å¹´ï¼æï¼ï¼æ¥ã«ä»£è¡¨çå»å¦èªã§ããã©ã³ã»ããã«æ²è¼ãããï¼ï¼äººã®å°é家ã®å£°æã§ãããå½¼ãã¯ä¸å½ã®ç 究è ãé¤è·ããç 究ææµåºèª¬ã¯é°è¬è«ã§ãããã¨ä¸»å¼µãã¦ããããã®å£°æã®ä¸å¿ã¨ãªã£ãã®ã¯ãã¼
2021.07.06 è»äºçãªç¶æ³ãç解ããã«æ¦äºç±ãç ½ãé²è¡å¯å¤§è£ ã«ãã´ãªï¼ã«ãã´ãªæªåé¡ ä¸å±±æ³°ç§é²è¡å¯å¤§è£ã¯6æ28æ¥ãã¢ã¡ãªã«ã®ã·ã³ã¯ã¿ã³ã¯ãããã½ã³ç 究æã§ã®è¬æ¼ã§ä¸å½ã¨ãã·ã¢ã®è å¨ã強調ãä¸å½ãããµã¤ã«ã§ã¢ã¡ãªã«ã®æ±æµ·å²¸ããã¯ã¤ããã¦ã¹ã«ç §æºãå®ãããã¨ã¯å¯è½ã ã¨èªã£ãããã ããã¢ã¡ãªã«ã¯1950年代ããããµã¤ã«ã§ä¸å½ãã½é£ãæ»æããè½åãæã£ã¦ããããããããã®æ»æè½åãã¢ã¡ãªã«ã¯å®éã«ä½¿ãè¨ç»ã ã£ããã¨ãæããã«ãªã£ã¦ãããä»ã§ãã¢ã¡ãªã«ã®åºæ¬æ¦ç¥ã¯ä¾µç¥ã§ãããæ¥æ¬ããå°æ¹¾ã«ããã¦ã®å¼§ç¶å島ã¯ä¾µç¥æ ç¹ãæ¥æ¬äººã¯åå µã¨è¦ãªããã¦ããã ããã ä¸å±±ã¯è¨åããªãã£ãããã ãããã·ã¢ãèªè¡ããã¦ãã巨大åååæ½æ°´è¦ããã«ã´ãããã«ã¯æ´¥æ³¢ãå¼ãèµ·ãããã¨ããæ ¸å¼¾é ãæè¼ããåååæ¨é²ã®æ°´ä¸ããã¼ã³ãæè¼ãããã¤ã®ãªã¹ã®ãµã³ç´ã¯ãã®ç©ºæ¯ããâã·ãã£ã»ãã©ã¼âãã¨å¼ãã§ããããã®ããã¼
å½é社ä¼ã®ãã¯ã¼ãã©ã³ã¹ãå¤ããä¸ãçµæ¸çå½±é¿åãä½ä¸ããæ¥æ¬ã¯ããã®ç«å ´ããã¡ãã¨ä¼ãããæ確ãªè¨èãã¯å¿ è¦ã¨ãªã£ããå®ååæ¿æ¨©ã¯ãèªç±ãæ°ä¸»ä¸»ç¾©ãæ³ã®æ¯é ãªã©ã®ä¾¡å¤è¦³ã§é£æºããã価å¤è¦³å¤äº¤ããæ²ãããããããæ¯ããã®ã¯ãæ´ä»£åã¨ãªãç·çå°å±ã¹ãã¼ãã©ã¤ã¿ã¼ã®åå¨ã ã£ãã ï¼ï¼ï¼ ä½è¤ãæ¨å¹´ãæ庫åããããã誰ãæ¸ããªãã£ãå®åæä¸ãï¼é£é³¥æ°ç¤¾ï¼ãåºãããã¾ã§ãè°·å£ããã¯ç¥ã人ãç¥ãåå¨ã§ãããå®åæ¿æ¨©ã§ã¯ç·çã®ã¹ãã¼ãã©ã¤ã¿ã¼ãåãã¦ãããã¾ãããã è°·å£ãã¯ãããã ãç§ãæ¸ããã®ã¯ãå¤äº¤ã«é¢ããæ¼èª¬ã ãã§ããæ信表ææ¼èª¬ãæ½æ¿æ¹éæ¼èª¬ã¯ããæ°å¤ãããå½å åãã®ãã®ã¯ãçåã®ããç§æ¸å®ãæ å½ãã¦ãã¾ããã è°·å£æºå½¦æ°ä½è¤ã2015å¹´4æã®ã¢ã¡ãªã«ã®é£é¦è°ä¼ä¸ä¸ä¸¡é¢ååä¼è°ã§ã®ã¹ãã¼ããæåã§ãã è°·å£ãç¥ç¶ã®å²¸ä¿¡ä»ã®è©±ããå§ãã¦ãæ¥ç±³ä¸¡å½ãèªç±ãæ°ä¸»ä¸»ç¾©ãæ³ã®æ¯é ã¨ãã£ã価å¤è¦³ãå ±æã
Most C.I.A. memoirs are terrible â defensive, jingoistic and worst of all, tedious. Others are doomed by the C.I.A.âs heavy-handed and mandatory censorship. There are exceptions, and that list includes the refreshingly candid âDebriefing the President: The Interrogation of Saddam Husseinâ by John Nixon. Mr. Nixon, the first C.I.A. officer to interrogate Hussein after his capture in December 2003,
ãã¯ã·ã³ãã³=æ°¸æ²¢æ¯ ãç±³å½å®¶å®å ¨ä¿éä¼è°ï¼NSCï¼ã®ãã£ã³ãã«ã»ã¤ã³ã太平æ´èª¿æ´å®ã¯6æ¥ãå°æ¹¾ã¨ã®é¢ä¿ã«ã¤ãã¦ãå¼·åã§éå ¬å¼ãªé¢ä¿ãæ¯æãã¦ããããç¬ç«ã¯æ¯æããªããã¨è¿°ã¹ããä¸å½å¤§é¸ã¨å°æ¹¾ã¯1ã¤ã®å½ã«å±ããã¨ãããä¸ã¤ã®ä¸å½ãæ¿çãæ´ä»£ç±³æ¿æ¨©ã¨åããè¸è¥²ããç«å ´ãæ¹ãã¦ç¤ºãããç±³ã·ã³ã¯ã¿ã³ã¯ã®ã¤ãã³ãã§èªã£ããæ´ä»£ã®ç±³æ¿æ¨©ã¯å°æ¹¾åé¡ã«ã¤ãã¦1972å¹´ã®ç±³ä¸å ±å声æãªã©ã§å½äºè ã«ãããå¹³åç解
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}